In the News September 11, 2018

The Pink Sheet | Could US Solve Drug Shortages with ‘Heightened’ M&A Scrutiny?

Marc Scheineson comments on a plan by the Food and Drug Administration to prevent drug shortages by examining pharma company mergers and acquisitions.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.